Sipuleucel-T (Sip-T)
Showing 1 - 25 of 8,128
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T
-
Oklahoma City, OklahomaStephenson's Cancer Center
Mar 28, 2023
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- mCRPC
- Sipuleucel-T
- Stereotactic Ablative Body Radiation
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 11, 2022
Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)
Prostate Cancer Trial in San Francisco, Houston (SipT Treatment, Ipilimumab)
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- Radiation Therapy
-
Buffalo, New York
- +1 more
Aug 4, 2021
Prostate Cancer Metastatic Trial in Duarte, Marina Del Rey, Honolulu (Atezolizumab1200 mg IV, Sipuleucel-T)
Completed
- Prostate Cancer Metastatic
- Atezolizumab1200 mg IV
- Sipuleucel-T
-
Duarte, California
- +2 more
May 24, 2021
Prostate Cancer Trial in Madison (sipuleucel-T, DNA Vaccine)
Completed
- Prostate Cancer
- sipuleucel-T
- DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jun 15, 2021
Prostate Cancer Recurrent Trial in Indianapolis (Low protein diet, Control protein diet)
Completed
- Prostate Cancer Recurrent
- Low protein diet
- Control protein diet
-
Indianapolis, Indiana
- +1 more
Mar 25, 2021
Metastatic Castrate-Resistant Prostate Cancer Treated With
Completed
- Prostate Cancer
- Enzalutamide
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Dec 22, 2020
Adenocarcinoma of the Prostate Trial in United States (sipuleucel-T)
Active, not recruiting
- Adenocarcinoma of the Prostate
- sipuleucel-T
-
Gilbert, Arizona
- +55 more
Jan 18, 2022
Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City
Completed
- Adenocarcinoma of the Prostate
- +5 more
- sipuleucel-T
- +2 more
-
Duarte, California
- +2 more
Aug 21, 2020
Metastatic Prostate Cancer Trial in United States (Indoximod, Sipuleucel-T, Placebo)
Completed
- Metastatic Prostate Cancer
- Indoximod
- +2 more
-
Chicago, Illinois
- +3 more
Mar 20, 2020
Prostate Cancer Trial in Durham (Sipuleucel-T, Lymph Node Biopsy)
Completed
- Prostate Cancer
- Sipuleucel-T
- Lymph Node Biopsy
-
Durham, North CarolinaDuke University Medical Center
Mar 30, 2020
Adverse Childhood Experiences Trial (FACE self-help App)
Not yet recruiting
- Adverse Childhood Experiences
- FACE self-help App
- (no location specified)
Apr 19, 2023
NEC, Atresia, Malrotation Trial (Perfusion assessment by means of the SPY-PHI camera)
Not yet recruiting
- NEC
- +3 more
- Perfusion assessment by means of the SPY-PHI camera
- (no location specified)
Feb 3, 2023
Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)
Terminated
- Prostatic Neoplasms
- CT-011 (Anti-PD1 Antibody)
- +2 more
-
Augusta, GeorgiaGeorgia Regents University
Jun 18, 2019
Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)
Not yet recruiting
- Peripheral T Cell Lymphoma
- CAR-T Therapy
-
Hefei, Anhui, China
- +7 more
Jul 31, 2023
Periodontal Diseases Trial in Turin (Decontamination of the pocket with local doxycycline, Decontamination of the pocket with
Recruiting
- Periodontal Diseases
- Decontamination of the pocket with local doxycycline
- Decontamination of the pocket with mechanical instrumentation
-
Turin, ItalyCIR Dental School
May 17, 2023
Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)
Recruiting
- Multiple Myeloma
- APRIL-BAFF-Bicephali CAR-T cells
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 14, 2023
Spinal Cord Injury Trial in Bronx (Natesto testosterone intranasal gel, Ayr Saline Nasal Gel)
Not yet recruiting
- Spinal Cord Injury
- Natesto testosterone intranasal gel
- Ayr Saline Nasal Gel
-
Bronx, New YorkJames J. Peters VA Medical Center, Bronx, NY
Nov 8, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Cyclophosphamide (Non-IMP, Lymphodepletion)
- +3 more
-
Ulm, Baden-Württemberg, Germany
- +4 more
Jul 24, 2023
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)
Not yet recruiting
- T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- CD7-CART01
- (no location specified)
Sep 26, 2023